Molecular basis of hypoxia-induced erythropoietin expression

Current Opinion in Hematology

Volumn 3, Issue 2, 1996, Pages 156-162

  Wang, Guang L ^a   Semenza, Gregg L ^b  

^a Otsuka American Pharmaceutical Inc   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; HEMOPROTEIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; OXYGEN; PROTEIN KINASE P60; RAS PROTEIN;

ENHANCER REGION; ERYTHROPOIESIS; GENE EXPRESSION; HUMAN; HYPOXIA; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0029890251     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603020-00009     Document Type: Review

References (93)

1. Jelkmann W: Erythropoietin: structure, control of production and function. Physiol Rev 1992, 72:449-489.
2. Schuster SJ, Badiavas EV, Costa-Giomi P, Weinmann R, Erslev AJ, Caro J: Stimulation of arythropoietin gene transcription during hypoxia and cobalt exposure. Blood 1989, 73:13-16.
3. Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE: Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin RNA and serum erythropoietin concentration. Blood 1989, 74:645-651.
4. Goldberg MA, Gaut CC, Bunn HF: Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 1991, 77:271-277.
5. Fandrey J, Bunn HF: In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 1993, 81:617-623.
6. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987, 316:73-78.
7. Villeval JL, Rouyer-Fessard P, Blumenfeld N, Henri A, Vainchenker W, Beuzard Y: Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia. Blood 1994, 84:928-933.
8. Osborne WRA, Ramesh N, Lau S, Clowes MM, Dale DC, Clowes AW: Gene therapy for long-term expression of erythropoietin in rats. Proc Natl Acad Sci U S A 1995, 92:8055-8058. Autologous vascular smooth muscle cells were transduced with a retroviral vector containing rat EPO complementary DNA sequences. Rats transplanted with the transduced cells developed significantly increased erythrocytic indices that were sustained for over 2 months.
9. Jacobson LO, Goldwasser E, Fried W, Plzak L: Role of the kidney in erythropoiesis. Nature 1957, 179:633-643.
10. Fried W: The liver as a source of extrarenal erythropoietin production. Blood 1972, 40:671-677.
11. Zanjani ED, Poster J, Burlington H, Mann LI, Wasserman LR: Liver as the primary site for erythropoietin formation in the fetus. J Lab Clin Med 1977, 89:640-644.
12. 125l-erythropoietin by the placenta. J Clin Invest 1988, 82:154-159.
13. Koury ST, Bondurant MC, Koury MJ: Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988, 71:524-527.
14. Lacombe C, Da Silva JL, Bruneval P, Fournier J, Wendling F, Casadevall N, Camilleri JP, Bariety J, Tambourin P, Varet B, Tambourin P: Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988, 81:620-623.
15. Darby IA, Evans BA, Fu P, Lim GB, Moritz KM, Wintour EM: Erythropoietin gene expression in fetal and adult sheep kidney. Br J Haematol 1995, 89:266-270.
16. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE: Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A 1991, 88:7825-7829.
17. Maxwell AP, Lappin TR, Johnston CF, Bridges JM, McGeowin MG: Erythropoietin production in kidney tubular cells. Br J Haematol 1990, 74:535-539.
18. Loya F, Yang Y, Lin H, Goldwasser E, Albitar M: Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood 1994, 84:1831-1836.
19. Koury ST, Bondurant MC, Koury MJ, Semenza GL. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 1991, 77:2497-2503.
20. Schuster SJ, Koury ST, Bohrer M, Salceda S, Caro J: Cellular sites of extrarenal and renal erythropoietin production in anemic rats. Br J Haematol 1992, 81:153-159.
21. Maxwell PH, Ferguson DJ, Osmond MK, Pugh CW, Heryet A, Doe BG, Johnson MH, Ratcliffe PJ: Expression of a homologously recombined erythropoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells. Blood 1994, 84:1823-1830. Further transgenic evidence supporting EPO expression within hepatocytes and nonparenchymal cells of the liver (see the paper by Koury et al. [Blood 1991, 77:2497-2503]). The nonparenchymal cells were identified as Ito cells, which were present in perisinusoidal sites with the space of Disse and showed structural similarities to the peritubular interstitial fibroblasts that produce erythropoietin in the kidney.
22. Maxwell PH, Ferguson DJ, Osmond MK, Pugh CW, Heryet A, Doe BG, Johnson MH, Ratcliffe PJ: Expression of a homologously recombined erythropoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells. Blood 1994, 84:1823-1830. Further transgenic evidence supporting EPO expression within hepatocytes and nonparenchymal cells of the liver (see the paper by Koury et al. [Blood 1991, 77:2497-2503]). The nonparenchymal cells were identified as Ito cells, which were present in perisinusoidal sites with the space of Disse and showed structural similarities to the peritubular interstitial fibroblasts that produce erythropoietin in the kidney.
23. Goldberg MA, Gloss GA, Cunningham JM, Bunn HF: The regulated expression of erythropoietin by two hepatoma cell lines. Proc Natl Acad Sci U S A 1987, 84:7972-7976.
24. Tan CC, Eckardt K-U, Firth JD, Ratcliffe PJ: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992, 263:F474-F481.
25. Semenza GL: Human erythropoietin gene expression in transgenic mice. In Overexpression and Knockout of Cytokines in Transgenic Mice. Edited by Jacob CO. London: Academic Press; 1994:125-134.
26. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M: Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A 1995, 92:3717-3720. Erythropoietin and erythropoietin receptor RNA were identified in mouse brain. Exposure of mice to 0.1% carbon monoxide increased brain erythropoietin RNA levels 20-fold. Specific erythropoietin binding sites within hippocampus, cortex, and midbrain were identified.
27. Masuda S, Okano, M, Yamagishi K, Nagao M, Ueda M, Sasaki R: A novel site of erythropoietin production. J Biol Chem 1994, 269:19488-19493. Demonstration of ecythropoietin production by astrocytes.
28. Konishi Y, Chui D-H, Hirose H, Kunishita T, Tabira T: Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 1993, 609:29-35.
29. Tan CC, Eckardt K-U, Ratcliffe PJ: Organ distribution of erythropoietin messenger RNA in normal and anemic rats studied by RNAase protection. Kidney Int 1991, 40:69-76.
30. Semenza GL, Nejfelt MK, Chi SM, Gearhart JD, Antonarakis SE: Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991, 88:5680-5684.
31. Beck I, Ramirez S, Weinmann R, Caro J: Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem 1991, 266:15563-15566.
32. Blanchard KL, Acquaviva AM, Galson DL, Bunn MF: Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 1992, 12:5373-5385.
33. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454.
34. Madan A, Curtin PT: A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci U S A 1993, 90:3928-3932.
35. Beck I, Weinmann R, Caro J: Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 1993, 82:704-711.
36. Wang GL, Semenza GL: Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993, 268:21513-21518.
37. Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993, 90:4304-4308.
38. Wang GL, Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 1993, 82:3610-3615.
39. Pugh CW, Ebert BL, Ebrahim O, Ratcliffe PJ: Characterization of functional domains within the mouse erythropoietin 3′ enhancer conveying oxygen-regulated responses in different cell lines. Biochem Biophys Acta 1994, 1217:197-306.
40. Galson DL, Tsuchiya T, Tenderler DS, Huang E, Ren Y, Ogura T, Bunn HF: The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol Cell Biol 1995, 15:2135-2144. Demonstration that HNF-4 can augment transcriptional activation mediated by the EPO enhancer in hypoxic cells.
41. Pugh CW, Tan CC, Jones RW, Ratcliffe PJ: Functional analysis of an oxygen regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc Natl Acad Sci U S A 1991, 88:10553-10557.
42. Maxwell PH, Pugh CW, Ratcliffe PJ: Inducible expression of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A 1993, 90:2423-2427.
43. Semenza GL, Traystman MD, Gearhart JD, Antonarakis SE: Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc Natl Acad Sci U S A 1989, 86:2301-2305.
44. Semenza GL, Dureza RC, Traystman MD, Gearhart JD, Antonarakis SE: Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol Cell Biol 1990, 10:930-938.
45. Madan A, Lin C, Hatch, SL, Curtin PT: Regulated basal, inducible and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 1995, 85:2735-2741. Further localization of cis-acting DNA sequences required for regulated EPO expression in vivo (see Semenza et al. [Proc Natl Acad Sci U S A 1991, 88:7825-7829]).
46. Madan A, Lin C, Hatch, SL, Curtin PT: Regulated basal, inducible and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 1995, 85:2735-2741. Further localization of cis-acting DNA sequences required for regulated EPO expression in vivo (see Semenza et al. [Proc Natl Acad Sci U S A 1991, 88:7825-7829]).
47. Beru N, Smith D, Goldwasser E: Evidence suggesting negative regulation of the erythropoietin gene by ribonucleoprotein. J Biol Chem 1990, 265:14100-14104.
48. Tsuchiya T, Ueda M, Ochiai H, Imajoh-Ohmi S, Kanegasaki S: Erythropoietin 5′-flanking sequence-binding protein induced during hypoxia and cobalt exposure. J Biochem 1993, 113:395-400.
49. Imagawa S, Izumi T, Miura Y: Positive and negative regulation of the erythropoietin gene. J Biol Chem 1994, 269:9036-9044.
50. Rondon IJ, MacMillan LA, Beckman BS, Goldberg MA, Schneider T, Bunn HF: Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J Biol Chem 1991, 266:16549-16598.
51. Rondon IJ, Scandurro AB, Wilson RB, Beckman BS: Changes in redox affect the activity of erythropoietin RNA binding protein. FEBS Lett 1995, 359:267-270.
52. Ho V, Acquaviva A, Duh E, Bunn HF: Use of a marked erythropoietin gene for investigation of its cis-acting elements. J Biol Chem 1995, 270:10084-10090. Identification of sequences in the 3′-untranslated region that affect erythropoietin RNA stability.
53. Wang GL, Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995, 270:1230-1237. Purification revealed that HIF-1 was a heterodimer and provided material for peptide microsequencing analysis essential for isolation of cognate complementary DNA sequences (see Wang et al. [Proc Natl Acad Sci U S A 1995, 92:5510-5514]).
54. Wang GL, Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995, 270:1230-1237. Purification revealed that HIF-1 was a heterodimer and provided material for peptide microsequencing analysis essential for isolation of cognate complementary DNA sequences (see Wang et al. [Proc Natl Acad Sci U S A 1995, 92:5510-5514]).
55. 2 tension. Proc Natl Acad Sci U S A 1995, 92:5510-5514. Isolation of complementary DNA encoding HIF-1α and HIF-1β and generation of antisera recognizing HIF-1α and HIF-1β polypeptides, thus allowing analysis of HIF-1α and HIF-1β RNA and protein expression in nonhypoxic, hypoxic, and posthypoxic cells.
56. Semenza GL, Roth PH, Fang H-M, Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994, 269:23757-23763.
57. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ: Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A 1994, 91:6494-6500.
58. Firth JD, Ebert BL, Ratcliffe PJ: Hypoxic regulation of lactate dehydrogenase A: interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem 1995, 270:21021-21027.
59. Levy AR, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor by hypoxia. J Biol Chem 1995, 270:13333-133340.
60. Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ Res 1995, 77:638-643.
61. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995, 182:1683-1693.
62. Hoffman EC, Reyes H, Chu F-F, Snader F, Conley LH, Brooks BA, Hankinson O: Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991, 252:954-958.
63. Burbach KM, Poland A, Bradfield CA: Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci U S A 1992, 89:8185-8189.
64. Nambu JR, Lewis JO, Wharton KA, Crews ST: The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNA midline development. Cell 1991, 67:1157-1167
65. Edery I, Rutila JE, Rosbash M: Phase shifting of the circadian clock by induction of the Drosophila period protein. Science 1994, 263:237-240.
66. Huang ZJ, Edery I, Rosbash M: PAS is a dimerization domain common to Drosophila period and several transcription factors. Nature 1993, 364:259-262.
67. Whitelaw ML, Gottlicher M, Gustafsson J-A, Poellinger L: Definition of a novel ligand binding domain of a nuclear bHLH receptor: colocalization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor. EMBO J 1993, 12:4169-4179.
68. Reisz-Porszasz S, Probst MR, Fukunaga BN, Hankinson O: Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol Cell Biol 1994, 14:6075-6066.
69. Dolwick KM, Swanson HI, Bradfield CA: In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc Natl Acad Scu U S A 1993, 90:8566-8570.
70. Goldberg MA, Dunning PS, Bunn HF: Regulation of the erythropoietin gene: evidence that oxygen sensor is a heme protein. Science 1988, 242:1412-1415.
71. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994, 269:4355-4359.
72. Tan CC, Ratcliffe PJ: Effect of inhibitors of oxidative phosphorylation on erythropoietin mRNA in Isolated perfused rat kidneys. Am J Physiol 1991, 261:F982-F987.
73. Gilles-Gonzalez MA, Ditta GS, Helinski D: A haemoprotein with kinase activity encoded by the oxygen sensor of Rhizobium meliloti. Nature 1991, 350:170-172.
74. Kullik I, Storz G: Transcriptional regulators of the oxidative stress response in prokaryotes and eukaryotes. Redox Rep 1994, 1:23-29.
75. Gorlach A, Holtermann G, Jelkmann W, Hancock JT, Jones SA, Jones OTG, Acker H: Photometric characteristics of haem proteins in erythropoietin-producing hepatoma cells (HepG2). Biochem J 1993, 290:771-776.
76. Fandrey J, Frede S, Jelkmann W: Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 1994, 30:507-510. Exposure of cells to hydrogen peroxide inhibited induction of EPO expression in response to hypoxia, suggesting a role for reactive oxygen intermediates in hypoxia signal transduction.
77. Fandrey J, Seydel FP, Siegers C-P, Jelkmann W: Role of cytochrome P450 in the control of the production of erythropoietin. Life Sci 1990, 47:127-134.
78. Buckler K, Vaughan-Jones R: Effects of hypoxia on membrane potential and intracellular calcium in rat neonatal carotid body type 1 cells. J Physiol 1994, 476:423-428.
79. Youngson C, Nurse C, Yeger H, Cutz E: Oxygen sensing in airway chemoreceptors. Nature 1993, 365:153-155.
80. Yuan X-J, Goldmann WF, Tod ML, Rubin LJ, Blaustein MP: Hypoxia induces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol 1993, 264:L116-L123.
81. 2 sensor in the rat carotid body. FEBS Lett 1989, 256:75-78.
82. 2++ entry and quantal dopamine secretion in carotid body glomus cells. Proc Natl Acad Sci U S A 1994, 91:10208-10211.
83. Wang GL, Jiang B-H, Semenza GL: Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem Biophys Res Commun 1995, 216:669-675.
84. Koong AC, Cheu EY, Giaccia AJ: Hypoxia causes the activation of nuclear factor κB through phosphorylation of lκ Bα on tyrosine residue. Cancer Res 1994, 54:1425-1430.
85. Koong AC, Cheu EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ: Hypoxic activation of nuclear factor-κ B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res 1994, 54:5273-5279.
86. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995, 375:577-581.
87. Kurtz A, Eckardt K-U, Pugh C, Corvol P, Fabbro D, Ratcliffe P: Phorbol ester inhibits erythropoietin production in human hepatoma cells (Hep G2). Am J Physiol 1992, 262:C1204-C1210.
88. Frede S, Fandrey J, Jelkmann W: Role of protein kinase C in hepatic erythropoietin synthesis. Exp Hematol 1995, 23:96-97.
89. Vannucchi AM, Crossi A, Rafanelli D, Statello M, Cinotti S, Rossi-Ferrini P: Inhibition of erythropoietin production in vitro by human interferon gamma. Br J Haematol 1994, 87:18-23.
90. Faquin W, Schneider TJ, Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992, 79:1987-1994.
91. Fandrey J, Huwiler A, Frede S, Pfeilschifter J, Jelkmann W: Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression. Eur J Biochem 1994, 226:335-340.
92. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, Herzenberg LA: Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci U S A 1994, 91:11527-11531.
93. Wang GL, Jiang B-H, Semenza GL: Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem Biophys Res Commun 1995, 212:550-556. Pretreatment of hypoxic cells with hydrogen peroxide blocked induction of HIF-1 protein expression. Treatment of purified HIF-1 with oxidizing agents in vitro resulted in loss of DNA-binding activity. Redox state may therefore affect both hypoxia signal transduction and HIF-1 activity directly.